Recard 50 mg (Tablet)
Unit Price: ৳ 0.78 (100's pack: ৳ 78.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Atenolol |
| Company | Rephco pharmaceuticals ltd |
Product Information
- Product Title:
- Recard
- Categories:
- Medicine
- Pharmaceutical
- Description:
- A medication indicated for the management of hypertension, angina pectoris, and acute myocardial infarction
Attributes
- Dimensions:
- N/A
- Color Options:
- N/A
- Functions:
- Management of hypertension
- Management of angina pectoris
- Reduction of cardiovascular mortality in acute myocardial infarction
- Materials:
- Atenolol
- Technical Specifications:
- Beta1 selective (cardioselective) beta-adrenergic receptor antagonist
- Design Elements:
- Tablet form
- Usability Features:
- Long-term management of patients with angina pectoris
- Reduction of cardiovascular mortality in acute myocardial infarction
- Dosage:
- Initial dose for hypertension: 50 mg once daily, may be increased to 100 mg once daily
- Initial dose for angina pectoris: 50 mg once daily, may be increased to 200 mg once daily
- Initial dose for acute myocardial infarction: 5 mg intravenous injection followed by 50 mg oral dose
- Interaction:
- Additive effect with catecholamine-depleting drugs
- Additive effect with calcium channel blockers
- Risk of severe bradycardia and heart failure when administered with disopyramide
- Additive negative chronotropic properties when administered with amiodarone
- Exacerbation of rebound hypertension when coadministered with clonidine
- Decreased hypotensive effects when used with prostaglandin synthase inhibiting drugs
- Risk of more severe allergic reaction in patients with a history of anaphylaxis
- Contraindications:
- Sinus bradycardia
- Heart block greater than first degree
- Cardiogenic shock
- Overt cardiac failure
- Hypersensitivity to atenolol or any components
- Side Effects:
- Agranulocytosis
- Fever and respiratory distress
- Reversible mental depression
- Mesenteric arterial thrombosis
- Skin rashes and dry eyes
- Erythematous rash
- Pregnancy & Lactation:
- Pregnancy Category D
- Caution advised for nursing women due to reported cases of bradycardia in breast-fed infants
- Precautions & Warnings:
- Aggravation of peripheral arterial circulatory disorders
- Caution in patients with impaired renal function
- Caution in elderly patients due to decreased hepatic, renal, or cardiac function
- Dose adjustment for patients with renal impairment
- Lower starting dose for hypertension in renal impaired or elderly patients
- Use in Special Populations:
- Dosage adjustment in cases of severe impairment of renal function
- Lower starting dose for elderly and renal impaired patients
- Dose adjustment for patients on hemodialysis
- Overdose Effects:
- Reported symptoms include lethargy, respiratory disorders, bradycardia, hypotension, and bronchospasm
- Treatment may involve induced emesis, gastric lavage, or hemodialysis
- Therapeutic Class:
- Beta-adrenoceptor blocking drugs
- Beta-blockers
- Storage Conditions:
- Do not use after the expiry date
- Keep out of the reach of children
- Dispense only on prescription of a registered physician